USPTO Examiner KIPOUROS HOLLY MICHAELA - Art Unit 1799

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18604469OPEN-TOP MICROFLUIDIC DEVICES AND METHODS FOR SIMULATING A FUNCTION OF A TISSUEMarch 2024February 2025Allow1120NoNo
18431281DEVICES, SYSTEMS, AND METHODS FOR REHYDRATION OF MICROORGANISMS TO ENHANCE AGRICULTURAL YIELDSFebruary 2024February 2025Allow1311YesNo
18571777Tissue Culture Vessel for Preparation of Compressed Hydrogel Skin Grafts and Related Methods And SystemsDecember 2023October 2024Allow1010NoNo
18525119CELL CULTURE VESSELNovember 2023January 2025Allow1420NoNo
18522531ILLUMINATION OF LIGHT DIFFUSING OPTICAL FIBERS, ILLUMINATION OF BLUE-VIOLET LIGHT DELIVERY SYSTEMS, BLUE-VIOLET LIGHT DELIVERY SYSTEMS, AND METHODS FOR BLUE-VIOLET LIGHT INDUCED DISINFECTIONNovember 2023January 2025Allow1411YesNo
18506801CELL VIABILITY APPARATUS, SYSTEM, AND METHODS THEREOFNovember 2023February 2024Allow410NoNo
18484560Drosophila Stock MaintenanceOctober 2023May 2024Allow700NoNo
18368174ENHANCED MACROALGAL PHOTOBIOREACTOR, ALGAE SCRUBBER, AND SEAWEED CULTIVATOR METHODS AND APPARATUSES - RESERVOIR DRAIN STRUCTURESSeptember 2023July 2024Allow1000YesNo
18450105APPARATUS AND METHOD FOR PRODUCING NANOEMULSIONSAugust 2023February 2025Allow1810NoNo
18448031Systems For Producing Cellular Immunotherapeutics And Methods Of Use ThereofAugust 2023February 2025Allow1820NoNo
18230996METHODS AND SYSTEMS FOR REAL-TIME ASSESSMENT OF CELLS IN ENCAPSULATION DEVICES PRE-AND POST-TRANSPLANTATIONAugust 2023October 2024Allow1410NoNo
18221313METHOD OF LOW-TEMPERATURE TREATMENT OF HOUSEHOLD WASTEJuly 2023November 2023Allow410YesNo
18328463EXPANDABLE SYSTEM FOR PURIFICATION AND DISINFECTION OF AIRJune 2023October 2024Allow1731YesNo
18140881METHODS AND DEVICES FOR STERILIZING MEDICAL EQUIPMENTApril 2023June 2024Allow1311YesNo
18031903Bioculture Meat DeviceApril 2023January 2025Allow2210NoNo
18128772SCAFFOLD BIOREACTORMarch 2023October 2023Allow720YesNo
18127638Uniform Material Distribution Control Method and System for Fermentation TankMarch 2023June 2024Abandon1521NoNo
18126296AIRLIFTING BIOREACTORMarch 2023August 2024Allow1731YesNo
18056035OPEN-TOP MICROFLUIDIC DEVICES AND METHODS FOR SIMULATING A FUNCTION OF A TISSUENovember 2022July 2023Allow810NoNo
17822508SYSTEMS AND METHODS FOR UV DECONTAMINATION OF RESPIRATORSAugust 2022December 2024Allow2821YesNo
17820174OPEN-TOP MICROFLUIDIC DEVICES AND METHODS FOR SIMULATING A FUNCTION OF A TISSUEAugust 2022November 2024Abandon2721NoNo
17879429INSTRUMENT FOR PERFORMING A DIAGNOSTIC TEST ON A FLUIDIC CARTRIDGEAugust 2022April 2025Allow3341NoNo
17664532SYSTEMS FOR PRODUCING CELLULAR IMMUNOTHERAPEUTICS AND METHODS OF USE THEREOFMay 2022May 2023Allow1200YesNo
17734562SYSTEM AND METHOD FOR FLUID FLOW MANAGEMENT IN A BIOPROCESSING SYSTEMMay 2022December 2024Allow3140NoNo
17724030ATOMIZATION DEVICE AND CULTURE DEVICEApril 2022June 2025Allow3820NoNo
17701141BIOREACTORS AND METHODS OF USEMarch 2022March 2025Abandon3511NoNo
17649639INACTIVATION APPARATUS AND INACTIVATION METHODFebruary 2022May 2025Abandon4001NoNo
17585338Drosophila Stock MaintenanceJanuary 2022July 2023Allow1810NoNo
17556842AUTOMATED APPARATUS FOR PERFUSION AND REPRODUCIBLE MULTI ORGAN DECELLULARIZATIONDecember 2021May 2025Abandon4010NoNo
17530336SEMI-QUANTITATIVE LATERAL-FLOW IMMUNOASSAY FOR THE DETECTION OF CSF LEAKSNovember 2021August 2023Allow2110NoNo
17609351Cell Settler Apparatus Systems and Methods for Perfusion ProcessesNovember 2021February 2025Allow3911YesNo
17452564ULTRAVIOLET LIGHT-EMITTING ASSEMBLYOctober 2021April 2025Allow4111YesNo
17507706TREATMENT AND AGITATION DEVICE FOR ULTRAVIOLET, TEMPERATURE AND GASEOUS CONTROLLED STERILIZATION, CURING AND TREATMENT OF AGRICULTURAL PRODUCTS INCLUDING CANNABIS, AND METHODS FOR TREATMENTOctober 2021September 2023Allow2310NoNo
17450173Combined UV Imaging and SanitizationOctober 2021June 2025Abandon4401NoNo
17495067INCUBATOR WITH ORBITAL SHAKEROctober 2021July 2023Allow2110NoNo
17490992CELL MAINTAINER FOR AUTOLOGOUS CELL THERAPY PRODUCTIONSeptember 2021September 2023Allow2310NoNo
17490896DISINFECTION DEVICESeptember 2021April 2025Abandon4201NoNo
17441923STERILIZATION STATUS DETECTION METHOD, STERILIZATION METHOD, STERILIZATION STATUS DETECTION DEVICE, STERILIZATION DEVICESeptember 2021April 2025Abandon4301NoNo
17438858MEDICAL DEVICE HAVING SPACE FOR ASSISTING IN EMBEDDING OF BIO SAMPLE IN EMBEDDING MATERIALSeptember 2021April 2025Allow4320NoNo
17473832PURIFICATION AND DETECTION OF ANALYTESSeptember 2021June 2023Allow2110NoNo
17463999Germicidal Donnable Hand ClothSeptember 2021February 2025Abandon4110NoNo
17462920BIOREACTOR FOR BIOLOGICAL MATERIALAugust 2021March 2025Abandon4310NoNo
17459131SHOPPING CART DISINFECTION SYSTEMAugust 2021April 2025Abandon4411NoNo
17406877UV MODULE, SYSTEM, AND METHOD FOR DEACTIVATING BIOLOGICALLY CONTAMINATED SURFACES IN AN INTERIOR OF A DEVICEAugust 2021December 2024Allow4011NoNo
17403939DISINFECTANT POUCH WITH FLUID CONTROLAugust 2021May 2022Allow930YesNo
17400610Disinfecting glove systemAugust 2021October 2023Allow2610NoNo
17393833VENTILATOR FILTER STERILIZATION SYSTEMS AND METHODSAugust 2021June 2025Abandon4611NoNo
17389054AUTOMATIC SURFACE DISINFECTIONJuly 2021February 2025Abandon4301NoNo
17382869PHOTODYNAMIC METHOD TO DECONTAMINATE SURFACESJuly 2021May 2025Abandon4620NoNo
17373060SYSTEM AND METHOD OF A PANEL ASSEMBLY FOR AIR TREATMENTJuly 2021January 2025Abandon4310NoNo
17421833DEVICE FOR DISINFECTING AT LEAST ONE OBJECTJuly 2021March 2025Abandon4420NoNo
17364288Devices Comprising Organoid Chambers and Uses Thereof to Culture, Maintain, Monitor or Test OrganoidsJune 2021August 2024Allow3720YesNo
17360585Gas Collection DeviceJune 2021January 2024Allow3010YesNo
17358452CEILING MOUNTED/POSITIONED (OVERHEAD) DELIVERY SYSTEMJune 2021February 2025Abandon4411NoNo
17356878SANITIZING DEVICE FOR VENDING MACHINESJune 2021November 2024Abandon4110NoNo
17356383SYSTEMS AND METHODS FOR UV DECONTAMINATION OF RESPIRATORSJune 2021April 2022Allow1020YesNo
17356336SHOE MANAGEMENT APPARATUSJune 2021November 2024Allow4120NoNo
17355169SYSTEMS, APPARATUS AND METHODS FOR PURIFYING AIRJune 2021February 2023Allow2041NoNo
17342141METHOD AND APPARATUS FOR DISINFECTING A VEHICLE INTERIORJune 2021March 2025Allow4521NoNo
17342250LIGHTING DEVICE WITH INTEGRAL UV DISINFECTIONJune 2021September 2024Allow3911YesNo
17341943INSTRUMENT FOR PERFORMING A DIAGNOSTIC TEST ON A FLUIDIC CARTRIDGEJune 2021August 2023Allow2610NoNo
17303773PEROXIDE-GENERATING AIR PURIFICATION ELEMENTJune 2021January 2025Allow4321NoNo
17299446DEVICE TO PREVENT CATHETER ASSOCIATED URINARY TRACT INFECTIONJune 2021January 2025Abandon4320NoNo
17337403MEMS-Based Virus TreatmentJune 2021February 2023Abandon2120NoYes
17298888MODELING TO ASSIST HIGH-LEVEL UV-C DISINFECTIONJune 2021September 2024Allow4011NoNo
17296711Device for Distributing a FlowMay 2021January 2025Allow4421YesNo
17323868SEPARATION USING ANGLED ACOUSTIC WAVESMay 2021October 2024Abandon4101NoNo
17317835CELL CULTURE INCUBATORS WITH INTEGRATED IMAGING SYSTEMSMay 2021January 2025Abandon4440NoNo
17316672AUTOMATED CELL CULTURE INCUBATORS COMPRISING SELECTIVELY PERMEABLE CELL CULTURE VESSEL STORAGE COMPARTMENTSMay 2021November 2024Allow4240NoNo
17235195Aseptically Connectable Sensor PatchApril 2021February 2025Allow4650NoNo
17233709SPHERE CULTURE MEMBER, CULTURE CONTAINER, METHOD FOR PROCESSING PERFORATED MEMBER, AND CLEANING CONTAINERApril 2021June 2025Allow5031YesNo
17234298BODY CUBE AND PROCESS FOR CULTURING TISSUEApril 2021October 2023Allow3011NoNo
17191088CELL RETAINERMarch 2021June 2025Allow5120NoNo
17190515SYSTEMS AND METHODS FOR THERMAL MANAGEMENT OF ALGAE CULTIVATION SYSTEMSMarch 2021March 2024Abandon3721NoNo
17186098Use of Plasma-Treated Liquids to Treat Herpes KeratitisFebruary 2021September 2024Abandon4310NoNo
17167915ORBITAL INCUBATOR SHAKERSFebruary 2021September 2023Allow3220NoNo
17165499MICROALGAE CULTURES USING SEALED VERTICAL PHOTOBIOREACTORSFebruary 2021October 2023Abandon3210NoNo
17156701BIOREACTOR SYSTEM AND METHODJanuary 2021July 2023Allow3010YesNo
170572943D CELL AUTOMATED INCUBATORJanuary 2021September 2023Allow3410NoNo
17153747CELL CULTURE, TRANSPORT AND INVESTIGATIONJanuary 2021September 2024Abandon4401NoNo
15733634DEVICE AND METHOD FOR STERILE SAMPLE-TAKINGJanuary 2021December 2024Abandon5111NoNo
17144751DIGESTER COMPRISING AN OXYGEN INJECTION SYSTEM HAVING A TUBULAR MEANS FORMED IN A GRID PATTERNJanuary 2021June 2024Abandon4140NoNo
17144762DIGESTER COMPRISING AN OXYGEN INJECTION SYSTEM HAVING A TUBULAR MEANS COMPRISING A T-SHAPED PORTIONJanuary 2021May 2024Abandon4020NoNo
17126670BIOMIMETIC INTERFACE DEVICE AND METHODS OF USING THE SAMEDecember 2020December 2023Allow3620NoNo
17253803PHOTOPOLYMERISED CELL CULTURE DEVICESDecember 2020August 2024Allow4411YesNo
17108475MULTIWELL DYNAMIC MODEL FOR A TUMOR-IMMUNE MICROENVIRONMENTDecember 2020July 2024Allow4311NoNo
17056623A CELL CULTURING PLATFORM, A CELL CULTURE SYSTEM, AND A METHOD FOR MODELING NEURAL ACTIVITY IN VITRONovember 2020February 2025Abandon5121NoNo
17098114LARGE SCALE MIXOTROPHIC PRODUCTION SYSTEMSNovember 2020January 2024Abandon3810NoNo
17054499DIELECTROPHORESIS AND DENSITY SEPARATORSNovember 2020April 2024Allow4111YesNo
17092869SWITCHING VALVE AND SUCTION-DISCHARGE DEVICE INCLUDING THE SAMENovember 2020February 2023Allow2700NoNo
17049608DISPENSING DEVICE HAVING A DISPENSER FOR DISPENSING A LIQUID CONTAINING AT LEAST ONE CELL AND/OR AT LEAST ONE PARTICLEOctober 2020February 2024Allow4010NoNo
17077326DISINFECTANT POUCH WITH FLUID CONTROLOctober 2020May 2021Allow720NoNo
17048740DISPOSABLE CARTRIDGE COOPERATING WITH A PLATFORM FOR A SYSTEM AND INSTALLATION FOR MONITORING AND CONTROLLING FLUIDSOctober 2020December 2024Allow5011NoNo
17047349COLLECTIONS AND MEASUREMENTS OF MICROFLUIDIC SAMPLESOctober 2020December 2024Abandon5021NoNo
17025352Filtered Enclosure for Cell Culture Samples for IncubatorsSeptember 2020October 2023Abandon3701NoNo
17023810METHOD AND APPARATUS FOR DISINFECTIONSeptember 2020February 2023Allow2900NoNo
17023190SYSTEMS AND METHODS FOR PROVIDING ULTRAVIOLET STERILIZATION, DISINFECTION AND DECONTAMINATION OF GAMING MACHINES AND ASSOCIATED EQUIPMENTSeptember 2020April 2021Allow710NoNo
16980147ULTRAHIGH THROUGHPUT PROTEIN DISCOVERYSeptember 2020June 2024Abandon4501NoNo
17016348COVID-19 DISINFECTANT HAND-HELD PORTABLE MISTING SPRAYER SYSTEM METHOD AND DEVICESSeptember 2020March 2022Abandon1811NoNo
17011601METHODS AND DEVICES FOR STERILIZING MEDICAL EQUIPMENTSeptember 2020March 2023Allow3021YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KIPOUROS, HOLLY MICHAELA.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
6
Examiner Affirmed
5
(83.3%)
Examiner Reversed
1
(16.7%)
Reversal Percentile
26.6%
Lower than average

What This Means

With a 16.7% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
15
Allowed After Appeal Filing
4
(26.7%)
Not Allowed After Appeal Filing
11
(73.3%)
Filing Benefit Percentile
35.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 26.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner KIPOUROS, HOLLY MICHAELA - Prosecution Strategy Guide

Executive Summary

Examiner KIPOUROS, HOLLY MICHAELA works in Art Unit 1799 and has examined 494 patent applications in our dataset. With an allowance rate of 66.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.

Allowance Patterns

Examiner KIPOUROS, HOLLY MICHAELA's allowance rate of 66.6% places them in the 20% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by KIPOUROS, HOLLY MICHAELA receive 2.11 office actions before reaching final disposition. This places the examiner in the 70% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by KIPOUROS, HOLLY MICHAELA is 33 months. This places the examiner in the 27% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +29.1% benefit to allowance rate for applications examined by KIPOUROS, HOLLY MICHAELA. This interview benefit is in the 80% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.1% of applications are subsequently allowed. This success rate is in the 29% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 45.6% of cases where such amendments are filed. This entry rate is in the 64% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 4% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 45.5% of appeals filed. This is in the 8% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 59.1% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 7% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.4% of allowed cases (in the 68% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.